Effect of Clopidogrel on Platelet Aggregation and Plasma Concentration of Fibrinogen in Subjects with Cerebral or Coronary Atherosclerotic Disease

Descarga: Effect of Clopidogrel on Platelet Aggregation and Plasma Concentration of Fibrinogen in Subjects with Cerebral or Coronary Atherosclerotic Disease Archivo: tromboembolia-arterial/Izaguirre.CPGRL.Clin Appl Throm Hemost.pdf Summary: Acetylsalicylic acid inhibits thromboxane A2 production and reduces the risk of vascular occlusive events by 20% to 25%. Ticlopidine inhibits ADP-dependent platelet aggregation and reduces the same risk by…

Leer más

Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease

Descarga: Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease Archivo: tromboembolia-arterial/cardiopatia/Thr Res 2018 Vernstrom-asp y diabetes.pdf Introduction: The antiplatelet effect of low-dose aspirin in patients with type 2 diabetes (T2DM) without cardiovascular disease (CVD) has not been thoroughly explored. We investigated if  platelet aggregation increased during the…

Leer más

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

Descargar PDF — Perioperative Management of Patients With Atrial Fibrillation Receiving a Dir… IMPORTANCE Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) and request elective surgery or procedure present a common clinical situation yet perioperative management is uncertain. OBJECTIVE To investigate the safety of a standardized perioperative DOAC managementstrategy. DESIGN, SETTING,…

Leer más

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

Descargar PDF — Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source BACKGROUND Embolic strokes of undetermined source represent 20% of ischemic strokes and are associated with a high rate of recurrence. Anticoagulant treatment with rivaroxaban, an oral factor Xa inhibitor, may result in a lower risk of recurrent stroke than aspirin.METHODS We compared…

Leer más

Move along, nothing to see here: Btk inhibitors stop platelets sticking to plaques

Descargar PDF — Move along, nothing to see here: Btk inhibitors stop platelets sticking to pl… Platelets have evolved an intricate array of overlapping mechanisms to respond effectively to vessel damage by forming a clot to minimize blood loss. Unfortunately, these same responses may also be triggered by atherosclerotic lesions in diseased arteries. Vessels can…

Leer más

Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke

Descargar PDF — Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke Ischemic stroke represents one of the leading causes of death and disability in both the United States and abroad, particularly for patients with prior ischemic stroke or transient ischemic attack (TIA). A quintessential aspect of secondary stroke prevention is the use of different…

Leer más

Trombocitopenia Inducida por Heparina (HIT)

Descargar PDF — Trombocitopenia Inducida por Heparina (HIT) Trombocitopenia Inducida por Heparina (HIT)Marta E MartinuzzoFundación Favaloro. Hospital Universitario. Buenos Aires, ArgentinaDefiniciónEs una reacción adversa del tratamiento con heparinas, es de origen inmunológico, se produce por la generación de anticuerpos dirigidos contra el complejo formado por el factor plaquetario 4 (PF4) y la heparina (Hep), que…

Leer más

Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban

Descarga: Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban Archivo: tromboembolia-venosa/tvp/th_2016-116-Suppl. 2_26558.pdf The vast clinical research programme for the direct, oral factor Xa inhibitor rivaroxaban has generated a wealth of data since the first  rivaroxaban approval in 2008 for the prevention of venous thrombo embolism (VTE) in patients undergoing elective hip or knee…

Leer más

Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban

Descarga: Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban Archivo: tromboembolia-venosa/tvp/th_2016-116-Suppl. 2_26558.pdf The vast clinical research programme for the direct, oral factor Xa inhibitor rivaroxaban has generated a wealth of data since the first  rivaroxaban approval in 2008 for the prevention of venous thrombo embolism (VTE) in patients undergoing elective hip or knee…

Leer más

Neutrophils in atherosclerosis

Descarga: Neutrophils in atherosclerosis Archivo: tromboembolia-venosa/tvp/haemo_2015-Neutrophils in atherosclerosis.pdf Atherosclerosis is a chronic inflammation of the arterial wall and the continuous infiltration of leukocytes into the plaque enhances the progression of the lesion. Because of the scarce detection of neutrophils in atherosclerotic plaques compared to other immune cells, their contribution was largely neglected. However, in the…

Leer más